Mesenchymal Stem Cell (MSC) Aggregate Formation in vivo.

Area of Science:

• Regenerative Medicine
• Cell Biology
• Immunology

Background:

• Human mesenchymal stem/progenitor cells (MSCs) exhibit significant therapeutic potential in clinical trials for various diseases.
• Intraperitoneal administration of MSCs in animal models has demonstrated profound beneficial effects.
• MSCs injected into the mouse peritoneum spontaneously form 3D sphere-like structures, mirroring in-vitro sphere formation.

Purpose of the Study:

• To describe the methodology for generating human bone marrow-derived MSC aggregates/spheres in vivo.
• To enable visualization, collection, and analysis of these in vivo MSC aggregates.
• To investigate changes in cellular properties and host immune cell interactions during MSC aggregate formation.

Main Methods:

• Generation of human bone marrow-derived MSC aggregates/spheres in vivo via intraperitoneal injection.
• Tagging MSCs with green fluorescent protein (GFP) for enhanced visualization.
• Collection and analysis of MSC aggregates to study cellular properties and immune cell interactions.

Main Results:

• MSCs injected into the peritoneum spontaneously aggregate into 3D sphere-like structures.
• During sphere assembly, MSCs upregulate the expression of anti-inflammatory and immune-modulatory factors.
• GFP-tagged MSC aggregates allow for easy visualization and subsequent analysis of cellular changes and host immune interactions.

Conclusions:

• The described method facilitates the in vivo generation and analysis of MSC aggregates.
• In vivo MSC aggregation is associated with the upregulation of therapeutic factors.
• This approach provides a valuable tool for studying MSC behavior and therapeutic mechanisms in vivo.